Gourt Home::Gourt :: Sodium valproate
Sodium valproate (INN) or valproate sodium (USAN) is the sodium salt of valproic acid and is an anticonvulsant used in the treatment of epilepsy. The intravenous formulations are used when oral administration is not possible.
Formulations
US
- Intravenous injection – Depacon® by Abbott Laboratories.
- Syrup – Depakene by Abbott Laboratories. (Note Depakene capsules are valproic acid).
UK & Australia
- Tablets – Orlept® by Wockhardt and Epilim® by Sanofi-Aventis.
- Oral solution – Orlept® Sugar Free by Wockhardt and Epilim® by Sanofi-Aventis.
- Syrup – Epilim® by Sanofi-Aventis.
- Intravenous injection – Epilim® Intravenous by Sanofi-Aventis.
- Extended release tablets – Epilim Chrono® by Sanofi-Aventis. A combination of sodium valproate and valproic acid in a 2.3:1 ratio.
Germany, Switzerland, Norway
- Tablets – Orfiril® by Desitin Pharmaceuticals
- Intravenous injection – Orfiril® IV by Desitin Pharmaceuticals
South Africa
- Syrup – Convulex® by Byk Madaus
Canada
- Intravenous injection – Epival® or Epiject® by Abbott Laboratories.
- Syrup – Depakene® by Abbott Laboratories. Generic formulations include Apo-Valproic and ratio-Valproic.
Others
In much of Europe, Depakine® and Depakine Chrono® are equivalent to Epilim and Epilim Chrono above.See also
References
"Sodium valproate"